Executive Summary
DOE dominates with $70B+ in nuclear security, renewables, and lab management contracts, signaling sustained U.S. prioritization of strategic R&D but limited public equity exposure due to private/non-profit recipients. NASA awards $7B+ across space infrastructure and operations, bullish for publics like Boeing ($2.2B SLS) and KBR amid Artemis momentum. Civilian IT/health wins for BAH ($990M total), Leidos, and others highlight $3B+ in federal modernization spend, offering diversified revenue visibility despite execution gaps.
Investment Signals(3)
- DOE Nuclear & Renewables Lock-In(HIGH)▲
Top 4 contracts total $68B for Y-12/Pantex, LBNL, NREL, NNSS management, affirming long-term revenue stability in critical infrastructure despite private recipients.
- NASA Space Program Acceleration(HIGH)▲
10+ NASA awards totaling $6.8B for SLS, Artemis landers, ground ops, and facilities boost Boeing, KBR, and space peers amid flagship program funding.
- Public Contractor Wins in Civ IT/Health(MEDIUM)▲
BAH secures $990M across VA/GSA/CDC; Leidos $953M DOE research; LMT $479M FAA NextGen provide material revenue ramps for defense/IT hybrids.
Risk Flags(3)
- Execution[HIGH RISK]▼
Technical complexity in nuclear labs, SLS stages, human landers, and D&D exposes cost overruns, especially with frequent $0 base/options signaling incremental funding.
- Regulatory[MEDIUM RISK]▼
DOE/NNSA oversight and recompetes loom for aging M&O contracts (e.g., 2005-2017 awards); NASA program delays could defer revenue.
- Market[MEDIUM RISK]▼
Private LLC dominance (20+ recipients) limits public market upside; historical awards (pre-2025) reduce near-term visibility.
Opportunities(3)
- ◆
Follow-on task orders/extensions in DOE labs (NREL, PPPL) and NASA Artemis/SLS could add $10B+ over 5-10 years.
- ◆
Civ agcy IT modernization (VA, CDC, IRS, DOI) totals $2B+ signaling multi-year demand for data/network services.
- ◆
Border/aviation security wins for Anduril, Northrop, Gulfstream position for DHS expansions amid policy shifts.
Sector Themes(3)
- ◆
80%+ of value in nuclear/renewables labs underscores $70B commitment to weapons complex and clean energy R&D.
- ◆
$7B across 12 contracts blends primes (Boeing) with new entrants (Blue Origin) in SLS/Artemis.
- ◆
15 contracts worth $4B+ target data, networks, and admin in VA/CDC/IRS/DOI.
Watch List(3)
- 👁
{"entity"=>"Booz Allen Hamilton (BAH)", "reason"=>"$990M wins in VA/CDC represent 2-3% of market cap upside with health IT exposure.", "trigger"=>"Q4 earnings revenue guide raise"}
- 👁
{"entity"=>"Boeing (BA)", "reason"=>"$2.2B SLS contract anchors space segment amid program delays.", "trigger"=>"Artemis launch milestones or option exercises"}
- 👁
{"entity"=>"Private Space Players (Blue Origin, Anduril)", "reason"=>"$2B+ awards signal valuation inflection; M&A targets.", "trigger"=>"Funding rounds or strategic partnerships"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC